Skip to content
January 22, 2025

Equity.Guru

Investment information for the new generation

Search
Latest News

NLSP.Q

23 July 2021
NLS Pharmaceutics (NLSP.Q) Announces FDA Acceptance to Initiate Quilience® Clinical…
NLS Pharmaceutics (NLSP.Q) announced today that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for Quilience® extended release, the Company’s lead drug…
15 July 2021
NLS Pharmaceutics (NLSP.Q) Announces FDA Acceptance to Initiate Quilience® Clinical…
NLS Pharmaceutics (NLSP.Q) announced today that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for Quilience® extended release, the Company’s lead drug…